Enhabit (EHAB) Competitors $7.05 +0.00 (+0.06%) Closing price 07/14/2025 03:59 PM EasternExtended Trading$7.30 +0.25 (+3.49%) As of 07:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EHAB vs. TDOC, VRDN, AHCO, CDNA, AGL, AVAH, PNTG, PSNL, FLGT, and INNVShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Agilon Health (AGL), Aveanna Healthcare (AVAH), The Pennant Group (PNTG), Personalis (PSNL), Fulgent Genetics (FLGT), and InnovAge (INNV). These companies are all part of the "healthcare" industry. Enhabit vs. Its Competitors Teladoc Health Viridian Therapeutics AdaptHealth CareDx Agilon Health Aveanna Healthcare The Pennant Group Personalis Fulgent Genetics InnovAge Teladoc Health (NYSE:TDOC) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation. Does the media prefer TDOC or EHAB? In the previous week, Teladoc Health had 4 more articles in the media than Enhabit. MarketBeat recorded 6 mentions for Teladoc Health and 2 mentions for Enhabit. Enhabit's average media sentiment score of 0.92 beat Teladoc Health's score of 0.67 indicating that Enhabit is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Enhabit 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate TDOC or EHAB? Teladoc Health presently has a consensus target price of $9.65, indicating a potential upside of 16.23%. Enhabit has a consensus target price of $8.75, indicating a potential upside of 24.04%. Given Enhabit's stronger consensus rating and higher probable upside, analysts plainly believe Enhabit is more favorable than Teladoc Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teladoc Health 0 Sell rating(s) 12 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.37Enhabit 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility & risk, TDOC or EHAB? Teladoc Health has a beta of 1.84, indicating that its stock price is 84% more volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500. Which has preferable valuation and earnings, TDOC or EHAB? Enhabit has lower revenue, but higher earnings than Teladoc Health. Enhabit is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeladoc Health$2.57B0.57-$1.00B-$5.92-1.40Enhabit$1.03B0.35-$156.20M-$2.77-2.55 Do insiders & institutionals believe in TDOC or EHAB? 76.8% of Teladoc Health shares are held by institutional investors. 0.6% of Teladoc Health shares are held by company insiders. Comparatively, 3.4% of Enhabit shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is TDOC or EHAB more profitable? Enhabit has a net margin of -13.43% compared to Teladoc Health's net margin of -39.66%. Enhabit's return on equity of 2.02% beat Teladoc Health's return on equity.Company Net Margins Return on Equity Return on Assets Teladoc Health-39.66% -11.01% -4.66% Enhabit -13.43%2.02%0.94% SummaryEnhabit beats Teladoc Health on 9 of the 16 factors compared between the two stocks. Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EHAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$357.19M$7.25B$5.54B$20.67BDividend YieldN/A2.83%5.01%3.71%P/E Ratio-2.5534.4128.6927.86Price / Sales0.3530.48372.4756.13Price / Cash1.7324.5224.7217.92Price / Book0.658.298.214.60Net Income-$156.20M$236.06M$3.19B$989.89M7 Day Performance-3.37%-0.24%3.60%0.43%1 Month Performance-27.80%2.72%9.61%5.50%1 Year Performance-23.24%28.58%30.04%9.92% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit2.4285 of 5 stars$7.05+0.1%$8.75+24.0%-25.6%$357.19M$1.03B-2.5510,700High Trading VolumeTDOCTeladoc Health2.7993 of 5 stars$8.06-2.8%$9.60+19.1%-11.6%$1.45B$2.57B-1.365,500VRDNViridian Therapeutics3.1897 of 5 stars$15.89+1.4%$37.56+136.3%+23.4%$1.28B$300K-4.1350AHCOAdaptHealth3.3123 of 5 stars$9.25-0.8%$13.40+44.9%-13.6%$1.26B$3.26B16.2310,500CDNACareDx4.1539 of 5 stars$18.45-4.1%$30.33+64.4%+25.8%$1.07B$333.79M16.04740AGLAgilon Health2.3928 of 5 stars$2.33-4.1%$4.79+105.4%-64.3%$1.01B$6.06B-3.951,076AVAHAveanna Healthcare2.1977 of 5 stars$4.30-7.5%$5.20+20.9%+27.6%$907.19M$2.02B215.0033,500High Trading VolumePNTGThe Pennant Group3.5998 of 5 stars$25.85-1.7%$34.60+33.8%-1.1%$906.53M$695.24M34.017,000News CoveragePositive NewsPSNLPersonalis3.4446 of 5 stars$6.68-10.3%$7.67+14.8%+289.8%$658.02M$84.61M-5.18400FLGTFulgent Genetics4.1194 of 5 stars$19.29-3.8%$24.00+24.4%-8.7%$610.70M$283.47M-14.501,313Positive NewsINNVInnovAge1.0152 of 5 stars$4.17-6.5%$5.00+19.9%-24.4%$602.16M$763.85M-18.132,350Gap Down Related Companies and Tools Related Companies TDOC Competitors VRDN Competitors AHCO Competitors CDNA Competitors AGL Competitors AVAH Competitors PNTG Competitors PSNL Competitors FLGT Competitors INNV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EHAB) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EHAB Stock Alerts